О. Гефверт

1.5k total citations
19 papers, 1.2k citations indexed

About

О. Гефверт is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, О. Гефверт has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in О. Гефверт's work include Schizophrenia research and treatment (10 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Receptor Mechanisms and Signaling (3 papers). О. Гефверт is often cited by papers focused on Schizophrenia research and treatment (10 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Receptor Mechanisms and Signaling (3 papers). О. Гефверт collaborates with scholars based in Sweden, United Kingdom and United States. О. Гефверт's co-authors include Bengt Långström, Leif Lindström, M Fredrikson, Ína Marteinsdóttir, Maria Tillfors, Tomas Furmark, Mariëlle Eerdekens, G Hagberg, W. Wolfgang Fleischhacker and W. Chrzanowski and has published in prestigious journals such as NeuroImage, Biological Psychiatry and Psychopharmacology.

In The Last Decade

О. Гефверт

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
О. Гефверт Sweden 10 695 275 262 243 172 19 1.2k
Wolfgang Fleischhacker Austria 14 922 1.3× 238 0.9× 182 0.7× 159 0.7× 227 1.3× 28 1.5k
Anthony S. Hale United Kingdom 19 405 0.6× 230 0.8× 188 0.7× 237 1.0× 179 1.0× 46 1.3k
Lena Flyckt Sweden 20 608 0.9× 293 1.1× 226 0.9× 106 0.4× 242 1.4× 50 1.2k
J. Alexander Bodkin United States 17 385 0.6× 314 1.1× 274 1.0× 190 0.8× 149 0.9× 38 1.3k
J. Fritze Germany 17 428 0.6× 404 1.5× 368 1.4× 176 0.7× 174 1.0× 56 1.4k
John R. Saksa United States 14 502 0.7× 398 1.4× 265 1.0× 226 0.9× 294 1.7× 17 1.2k
Fabrice Duval France 23 434 0.6× 338 1.2× 217 0.8× 158 0.7× 173 1.0× 90 1.5k
W. Rein France 16 1.1k 1.5× 199 0.7× 305 1.2× 196 0.8× 122 0.7× 48 1.5k
Masahiro Asai Japan 21 390 0.6× 315 1.1× 269 1.0× 130 0.5× 117 0.7× 51 1.3k
J M Perel United States 21 433 0.6× 450 1.6× 220 0.8× 263 1.1× 195 1.1× 31 1.3k

Countries citing papers authored by О. Гефверт

Since Specialization
Citations

This map shows the geographic impact of О. Гефверт's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. Гефверт with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. Гефверт more than expected).

Fields of papers citing papers by О. Гефверт

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. Гефверт. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. Гефверт. The network helps show where О. Гефверт may publish in the future.

Co-authorship network of co-authors of О. Гефверт

This figure shows the co-authorship network connecting the top 25 collaborators of О. Гефверт. A scholar is included among the top collaborators of О. Гефверт based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with О. Гефверт. О. Гефверт is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Levander, Sten, et al.. (2006). Psykiatri. En orienterande översikt.. Lund University Publications (Lund University). 1 indexed citations
2.
Гефверт, О., Bo Eriksson, Per Persson, et al.. (2005). Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia. The International Journal of Neuropsychopharmacology. 8(1). 27–36. 88 indexed citations
3.
Гефверт, О., Leif Lindström, Nicholas Waters, Arvid Carlsson, & Joakim Tedroff. (2003). Different corticostriatal patterns of L‐DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scandinavian Journal of Psychology. 44(3). 289–292. 20 indexed citations
4.
Fleischhacker, W. Wolfgang, Mariëlle Eerdekens, Keith Karcher, et al.. (2003). Treatment of Schizophrenia With Long-Acting Injectable Risperidone. The Journal of Clinical Psychiatry. 64(10). 1250–1257. 253 indexed citations
5.
Eerdekens, Mariëlle, W. Wolfgang Fleischhacker, Xue Yang, et al.. (2002). Long-term safety of long-acting risperidone microspheres. European Psychiatry. 17. 193–193. 9 indexed citations
6.
Гефверт, О., et al.. (2001). D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. European Neuropsychopharmacology. 11(2). 105–110. 93 indexed citations
7.
Гефверт, О.. (2000). PET studies in schizophrenia: Functional and pharmacological studies. Nordic Journal of Psychiatry. 54(4). 297–297. 5 indexed citations
8.
Furmark, Tomas, et al.. (1999). Social phobia in the general population: prevalence and sociodemographic profile. Social Psychiatry and Psychiatric Epidemiology. 34(8). 416–424. 288 indexed citations
9.
Lindström, Leif, et al.. (1999). Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET. Biological Psychiatry. 46(5). 681–688. 213 indexed citations
10.
Davis, Patricia C., James R. Wong, & О. Гефверт. (1999). Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis. 20(1-2). 271–282. 60 indexed citations
11.
12.
Hagberg, G, О. Гефверт, Mats Bergström, et al.. (1998). N-[11C]Methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Research Neuroimaging. 82(3). 147–160. 24 indexed citations
13.
Hagberg, G, О. Гефверт, L. Lindström, Mats Bergström, & Bengt Långström. (1998). L-[β-11C]DOPA Utilization in Schizophrenia. NeuroImage. 7(4). A45–A45. 2 indexed citations
14.
Hagberg, G, О. Гефверт, L. Lindström, Mats Bergström, & Bengt Långström. (1998). D2 Receptor Occupancy Determined by 11C-Raclopride PET and Reference Region Methods. NeuroImage. 7(4). A20–A20. 1 indexed citations
15.
Hagberg, G, et al.. (1998). (11C)-N-Methylspiperone pet detects different levels of dopamine D2 receptor occupancy of an atypical neuroleptic than (11C)-raclopride pet. Schizophrenia Research. 29(1-2). 165–166. 1 indexed citations
16.
17.
Гефверт, О., et al.. (1997). P.2.111 D2 and 5 HT2A receptor binding of different doses of quetiapine in schizophrenics, a pet study. European Neuropsychopharmacology. 7. S227–S227. 3 indexed citations
18.
Гефверт, О., et al.. (1996). Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 MG ‘seroquel’ TID. Schizophrenia Research. 18(2-3). 139–140. 2 indexed citations
19.
Гефверт, О., et al.. (1995). P-4-65 Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg Seroquel™ tid. European Neuropsychopharmacology. 5(3). 347–347. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Fleischhacker Breakdown of academic impact, for papers by Anthony S. Hale Breakdown of academic impact, for papers by Lena Flyckt Breakdown of academic impact, for papers by J. Alexander Bodkin Breakdown of academic impact, for papers by J. Fritze Breakdown of academic impact, for papers by John R. Saksa Breakdown of academic impact, for papers by Fabrice Duval Breakdown of academic impact, for papers by W. Rein Breakdown of academic impact, for papers by Masahiro Asai Breakdown of academic impact, for papers by J M Perel
Rankless by CCL
2026